<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-14T03:18:34Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:11351/10919" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:11351/10919</identifier><datestamp>2025-10-24T10:30:57Z</datestamp><setSpec>com_2072_378070</setSpec><setSpec>com_2072_378040</setSpec><setSpec>col_2072_378092</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology</dc:title>
   <dc:creator>Fernández Montes, Ana</dc:creator>
   <dc:creator>Haba Rodríguez, Juan Rafael de la</dc:creator>
   <dc:creator>Páez, David</dc:creator>
   <dc:creator>Elez, Elena</dc:creator>
   <dc:creator>Mendez-Vidal, Maria Jose</dc:creator>
   <dc:creator>FELIP, ENRIQUETA</dc:creator>
   <dc:contributor>Institut Català de la Salut</dc:contributor>
   <dc:contributor>[Fernandez Montes A] Department of Medical Oncology, University Hospital Complex of Ourense (CHUO), Ourense, Galicia, Spain. [Elez E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [de la Haba Rodriguez J] Medical Oncology Department, Reina Sofa University Hospital, Maimonides Institute for Biomedical Research in Cordoba, Córdoba, Spain. [Paez D] Department of Medical Oncology, Santa Creu I Sant Pau University Hospital, U705, ISCIII Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Barcelona, Catalunya, Spain. [Mendez Vidal MJ] Medical Oncology Department, Maimonides Institute for Biomedical Research in Cordoba, Reina Sofa University Hospital, Córdoba, Spain. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain</dc:contributor>
   <dc:contributor>Vall d'Hebron Barcelona Hospital Campus</dc:contributor>
   <dc:subject>Oncologia</dc:subject>
   <dc:subject>Decisió de grup</dc:subject>
   <dc:subject>Treball - Mesurament</dc:subject>
   <dc:subject>NAMED GROUPS::Persons::Occupational Groups::Health Personnel::Physicians::Oncologists</dc:subject>
   <dc:subject>PSYCHIATRY AND PSYCHOLOGY::Behavior and Behavior Mechanisms::Psychology, Social::Group Processes::Consensus</dc:subject>
   <dc:subject>HEALTH CARE::Health Services Administration::Organization and Administration::Personnel Management::Personnel Staffing and Scheduling::Workload</dc:subject>
   <dc:subject>DENOMINACIONES DE GRUPOS::personas::grupos profesionales::personal sanitario::médicos::oncólogos</dc:subject>
   <dc:subject>PSIQUIATRÍA Y PSICOLOGÍA::conducta y mecanismos de la conducta::psicología social::procesos de grupo::consenso</dc:subject>
   <dc:subject>ATENCIÓN DE SALUD::administración de los servicios de salud::organización y administración::gestión de personal::admisión y programación del personal::carga de trabajo</dc:subject>
   <dc:description>Medical oncologist; Spain; Workload</dc:description>
   <dc:description>Médico oncólogo; España; Carga de trabajo</dc:description>
   <dc:description>Metge oncòleg; Espanya; Càrrega de treball</dc:description>
   <dc:description>Purpose&#xd;
Growing complexity and demand for cancer care entail increased challenges for Medical Oncology (MO). The Spanish Society of Medical Oncology (SEOM) has promoted studies to provide updated data to estimate the need for medical oncologists in 2040 and to analyse current professional standing of young medical oncologists.&#xd;
Methods&#xd;
Two national, online surveys were conducted. The first (2021) targeted 146 Heads of MO Departments, and the second (2022), 775 young medical oncologists who had completed their MO residency between 2014 and 2021. Participants were contacted individually, and data were processed anonymously.&#xd;
Results&#xd;
Participation rates reached 78.8% and 48.8%, respectively. The updated data suggest that 87–110 new medical oncologist full-time equivalents (FTEs) should be recruited each year to achieve an optimal ratio of 110–130 new cases per medical oncologist FTE by 2040. The professional standing analysis reveals that 9.1% of medical oncologists trained in Spain do not work in clinical care in the country, with tremendous employment instability (only 15.2% have a permanent contract). A high percentage of young medical oncologists have contemplated career paths other than clinical care (64.5%) or working in other countries (51.7%).&#xd;
Conclusions&#xd;
Optimal ratios of medical oncologists must be achieved to tackle the evolution of MO workloads and challenges in comprehensive cancer care. However, the incorporation and permanence of medical oncologists in the national healthcare system in Spain could be compromised by their current sub-optimal professional standing.</dc:description>
   <dc:description>This study was funded by Janssen Pharmaceuticals.</dc:description>
   <dc:date>2024-01-29T07:59:55Z</dc:date>
   <dc:date>2024-01-29T07:59:55Z</dc:date>
   <dc:date>2024-01</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>Fernandez Montes A, Elez E, De La Haba-Rodriguez J, Paez D, Mendez-Vidal MJ, Felip E, et al. Medical oncology workload, workforce census, and needs in Spain: two nationwide studies by the Spanish Society of medical oncology. Clin Transl Oncol. 2024 Jan;26:98–108.</dc:identifier>
   <dc:identifier>1699-048X</dc:identifier>
   <dc:identifier>https://hdl.handle.net/11351/10919</dc:identifier>
   <dc:identifier>10.1007/s12094-023-03225-2</dc:identifier>
   <dc:identifier>37316754</dc:identifier>
   <dc:identifier>001005805100001</dc:identifier>
   <dc:identifier>http://hdl.handle.net/11351/10919</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Clinical and Translational Oncology;26</dc:relation>
   <dc:relation>https://doi.org/10.1007/s12094-023-03225-2</dc:relation>
   <dc:rights>Attribution 4.0 International</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Springer</dc:publisher>
   <dc:source>Scientia</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>